We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMpac Group Plc Regulatory News (MPAC)

Share Price Information for Mpac Group Plc (MPAC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 425.00
Bid: 420.00
Ask: 430.00
Change: 0.00 (0.00%)
Spread: 10.00 (2.381%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 425.00
MPAC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19, trading update and AGM

26 Mar 2020 07:00

RNS Number : 6108H
Mpac Group PLC
26 March 2020
 

26 March 2020

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No. 596/2014

 

Mpac Group plc

(''Mpac'', "Company" or "Group")

 

COVID-19, trading update and AGM

 

COVID-19 and trading update

 

Mpac Group plc, a global leader in 'Make, Pack, Monitor and Service' high speed packaging and automation solutions issues an update to the market on current year trading.

 

In the light of the rapidly evolving situation resulting from the spread of COVID-19 and its development into a global pandemic, Mpac today provides an update on the Group's current trading and operations. Our priority remains the health, safety and well-being of our employees and essential support for our customers.

 

The latest government travel restrictions in the regions of our main sites, UK, Netherlands and Canada, and measures implemented are being evaluated and are having an immediate impact, restricting customer interaction and site-based work. However, Mpac remains dedicated to the provision of equipment, spares and services for customers in the critical sectors of Healthcare and Food and Beverage and we are utilising increased remote working wherever practical and possible.

 

The Board is continually monitoring the rapidly changing global situation regarding the COVID-19 pandemic. Whilst it remains difficult to predict the length and depth of the impact for the full year at this stage, the Board anticipates that order intake will be lower than expected due to reduced demand as a result of customers deferring investment decisions and current projects being delayed due to travel restrictions.

 

Given the fast moving and unprecedented nature of the current crisis, we are unable to predict how long this lower level of order activity will last and therefore the impact on the Group's business. Accordingly, in the immediate term we are scrutinising discretionary spend and investment plans, identifying and implementing cost saving initiatives, whilst seeking to protect our talented workforce and being careful not to compromise the long-term prospects of the business. We are also evaluating government support measures available in the jurisdictions in which we operate.

 

Mpac has a strong balance sheet, is well financed and remains debt free and is therefore very well positioned to navigate the COVID-19 pandemic. The Group has c.£19m of cash and cash generation in the first two months of the year was in line with management's expectations. Additionally, the Group has access to a £10m secured committed revolving facility which is currently fully undrawn. Even in cautious downside scenarios which we have modelled, and stress tested, we expect to have sufficient liquidity from existing resources to meet our needs throughout 2020.

 

However, in light of the exceptional and open-ended uncertainty caused by the Covid-19 pandemic and the still rapidly changing environment, the Board has taken the prudent decision to no longer recommend the final dividend for the year ending 31 December 2019, as a further measure to protect the business and conserve cash during this period. This decision comes after finalising the Notice of Meeting in respect of the Annual General Meeting for 2020 which is scheduled to be posted to Shareholders on 1 April 2020. Therefore, the Board intends to withdraw Resolution number 2 in the Notice of Annual General Meeting relating to the approval of a proposed final dividend of 1.5p per Ordinary.

 

Annual General Meeting ("the Meeting")

 

The Company is planning to proceed with the Meeting, which will be held at 12 noon on Wednesday 6 May 2020. However, the evolving COVID-19 situation and the related Government guidelines will clearly impact the ability of shareholders to attend the Meeting. On this basis, the Board has concluded that it is appropriate for shareholders not to attend in person this year and, instead, to submit proxy votes. Details on submitting proxy votes are contained in the Notice of Meeting. We always welcome questions from our shareholders at the Annual General Meeting but this year, we would rather shareholders submit their questions to the Board before the Meeting, and we will ensure that answers to the questions are placed on the Company's website. You can submit questions up until 5pm on 5 May 2020 by emailing them to cosec@mpac-group.com.

 

The situation in relation to COVID-19 continues to develop and we will update shareholders on the Company's website www.mpac-group.com and through the Regulatory News Service.

 

The Board remains confident in the ability of the management teams across the Group to manage the business through difficult times and to ensure that Mpac is well placed when the market returns to normality.

 

 

For further information, please contact:

Mpac Group plc

Tony Steels, Chief Executive

Will Wilkins, Group Finance Director

 

Tel: +44(0)24 7642 1100

Shore Capital (Nominated Adviser & Broker)

Patrick Castle

Edward Mansfield

Sarah Mather

 

Tel: +44(0)20 7468 7923

 

Hudson Sandler

Nick Lyon

Nick Moore

 

Tel: +44(0)20 7796 4133

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBLGDXUBDDGGU
Date   Source Headline
17th Apr 20247:00 amRNSLaunch of ESG Report
9th Apr 20241:12 pmRNSGrant of Options
8th Apr 20242:15 pmRNSNotice of AGM
19th Mar 20247:00 amRNSFull Year Results
21st Feb 20247:00 amRNSEquity Development Investor Presentation
16th Feb 20247:00 amRNSNotice of Results
11th Jan 20247:00 amRNSFull Year Trading Update
4th Dec 202311:51 amRNSDirector/PDMR Shareholding
27th Nov 202311:36 amRNSDirector/PDMR Dealing
18th Oct 20232:42 pmRNSHolding(s) in Company
12th Oct 20237:00 amRNSAppointment of Joint Broker
22nd Sep 202311:19 amRNSHolding(s) in Company
7th Sep 20237:00 amRNSHalf Year Results
17th Aug 20237:00 amRNSEquity Development Investor Webinar
11th Jul 20237:00 amRNSTrading Update and Notice of Results
30th May 202310:52 amRNSDirector/PDMR Shareholding
18th May 202311:17 amRNSResult of Annual General Meeting
17th May 20237:00 amRNSAGM Statement
2nd May 20234:37 pmRNSDirector/PDMR Transaction
6th Apr 20235:30 pmRNSAvailability of Annual Report and Notice of AGM
27th Mar 202310:53 amRNSDirector/PDMR Dealing
22nd Mar 20237:01 amRNSCEO succession
22nd Mar 20237:00 amRNSFull Year Results
20th Feb 20237:00 amRNSEquity Development Investor Presentation
17th Feb 20237:00 amRNSNotice of Results
16th Jan 20237:00 amRNSFull Year Trading Update
24th Oct 20222:20 pmRNSDirectorate Appointment
14th Oct 202210:58 amRNSReplacement - PDMR Dealing & Total Voting Rights
12th Oct 20224:59 pmRNSDirector/PDMR Dealing & Total Voting Rights
15th Sep 202212:50 pmRNSMpac signs FREYR framework agreement
13th Sep 20227:00 amRNSEquity Development Investor Presentation
9th Sep 20222:16 pmRNSDirector/PDMR Transaction
8th Sep 20227:00 amRNSHalf Year Result
11th Jul 20227:00 amRNSTrading Update and Notice of Results
24th Jun 20222:54 pmRNSAppointment of new auditor
10th Jun 20224:10 pmRNSGrant of Options
27th May 20222:56 pmRNSDirectors/PDMRs Dealing
25th May 20224:13 pmRNSHolding(s) in Company
19th May 20223:57 pmRNSEBT Subscription & Total Voting Rights
13th May 20224:25 pmRNSDirectors/PDMRs Dealing - Replacement
12th May 20224:46 pmRNSDirectors/PDMRs Dealing
4th May 20224:16 pmRNSResult of AGM
4th May 20227:00 amRNSAGM Statement
17th Mar 20227:00 amRNSFull Year Results
14th Feb 20224:38 pmRNSNotice of Results
12th Jan 20227:00 amRNSFull Year Trading Update
21st Oct 20215:16 pmRNSDirectorate Appointment
2nd Sep 20217:00 amRNSHalf Year Results
13th Aug 20217:00 amRNSEquity Development Investor Webinar
27th Jul 20217:00 amRNSChange of Registered Office Address

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.